Alan M Mathiowetz

Title: Alan M Mathiowetz: Innovator in Pharmaceutical Chemistry

Introduction

Alan M Mathiowetz is a notable inventor based in Schwenksville, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 2 patents, his work focuses on innovative solutions for treating diseases related to matrix metalloproteinases.

Latest Patents

Mathiowetz's latest patents include a groundbreaking disclosure on hydroxamic acid and carboxylic acid derivatives. This disclosure relates to a novel class of hydroxamic and carboxylic acid-based matrix metalloproteinase inhibitor derivatives. Furthermore, it encompasses pharmaceutical compositions containing such compounds and their use in treating matrix metalloproteinase-induced diseases. His research in this area highlights the potential for new therapeutic options in the medical field.

Career Highlights

Throughout his career, Mathiowetz has worked with prominent companies such as Sterling Winthrop Inc. and Sanofi S.A. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations. His contributions have been instrumental in advancing the understanding and application of matrix metalloproteinase inhibitors.

Collaborations

Mathiowetz has collaborated with several professionals in his field, including Madhusudhan R Gowravaram and Jeffrey Johnson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alan M Mathiowetz stands out as a significant figure in the realm of pharmaceutical chemistry. His innovative patents and collaborations reflect his commitment to advancing medical science. His work continues to inspire future developments in the treatment of complex diseases.